A smiling Stephen Hawking has been pictured alongside two women in bikinis sipping on cocktails in a fresh photo discovered in the Epstein Files. The late British physicist is seen lounging next to ...

LOVB Austin opposite Madisen Skinner made headlines when she suggested merging the United States' two pro volleyball leagues, providing a single place for the best players in the sport. Skinner, a ...

Six associates of late pedophile Jeffrey Epstein were “likely incriminated” by their inclusion in voluminous files detailing the years-long investigation of the notorious financier, Reps. Ro Khanna (D ...

The latest disclosure from the U.S. Department of Justice’s investigation of Jeffrey Epstein is threatening the U.K. ruling government. New documents have led Peter Mandelson, a former ambassador to ...

How far are you willing to go to make a buck? For Tesla shareholders, looking the other way when two board members had close relationships with the head of a sex trafficking organization, and lied ...

Sky News' James Matthews reacts to the new batch of Epstein files. Migrant centre on 'brink of collapse' after influx of 1,000 African asylum seekers Trump hits Britain with higher tariffs Nadiya ...

Three of Elon Musk’s companies — SpaceX, xAI, and Tesla — are in play for a potential merger. While the talks appear to be in the early stage, according to reports from Bloomberg and Reuters, it could ...

The share of Americans who are satisfied with the amount of Jeffrey Epstein-related files released so far is in the single digits, new polling shows. Just 6 percent of Americans in a CNN survey said ...

Threat actors have been observed leveraging malicious dropper apps masquerading as legitimate applications to deliver an Android SMS stealer dubbed Wonderland in mobile attacks targeting users in ...

Two peer-to-peer boat-rental platforms are merging. Boatsetter and GetMyBoat, online platforms that allow users to rent boats of various types from other users, have signed a deal to combine, ...

On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating to the characterization of recombinant adeno-associated virus ...